Medicine & Life Sciences
Thrombotic Thrombocytopenic Purpura
100%
Antiphospholipid Syndrome
63%
Idiopathic Thrombocytopenic Purpura
39%
Antiphospholipid Antibodies
33%
Thrombosis
29%
Sickle Cell Anemia
26%
eculizumab
26%
Thrombocytopenia
24%
Atypical Hemolytic Uremic Syndrome
22%
Thrombotic Microangiopathies
21%
Complement Activation
21%
Alternative Complement Pathway
20%
Survivors
18%
Blood Platelets
15%
Mortality
15%
Pregnancy
14%
Bloodless Medical and Surgical Procedures
14%
Stroke
13%
Complement Membrane Attack Complex
12%
Hereditary Hemorrhagic Telangiectasia
11%
Therapeutics
10%
Recurrence
10%
Rituximab
9%
Hemorrhage
9%
ravulizumab
9%
Coronavirus Spike Glycoproteins
9%
Mutation
9%
Hemolysis
9%
Heparin
8%
von Willebrand Factor
8%
Post-Traumatic Stress Disorders
8%
Plasma Exchange
8%
Severe Acute Respiratory Syndrome
8%
Thrombophilia
8%
Glycoproteins
8%
Prostatic Neoplasms
7%
Cardiovascular Diseases
7%
Confidence Intervals
7%
Hemoglobin SC Disease
7%
Risk Assessment
7%
HELLP Syndrome
6%
Complement Factor D
6%
Quality of Life
6%
Morbidity
6%
Aspirin
6%
Lupus Coagulation Inhibitor
6%
Thromboplastin
6%
Acute Chest Syndrome
6%
Biomarkers
6%